D. Miskulin

发表

Role of Renin-Angiotensin-Aldosterone System Inhibition in Autosomal Dominant Polycystic Kidney Disease

P. Garimella, D. Miskulin, 2018 .

Blood pressure in early autosomal dominant polycystic kidney disease.

Kaleab Z. Abebe, Charity G Moore, K. Bae, 2014, The New England journal of medicine.

Liver involvement in early autosomal-dominant polycystic kidney disease.

Kaleab Z. Abebe, K. Bae, C. Moore, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Klaus Romero, Arlene B. Chapman, 2017, Kidney international reports.

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Klaus Romero, Arlene B. Chapman, 2017, Kidney international reports.

The HALT polycystic kidney disease trials: design and implementation.

J. Miller, K. Bae, P. Thompson, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Computerized decision support for EPO dosing in hemodialysis patients.

Daniel E Weiner, H. Tighiouart, K. Servilla, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comorbidity and its change predict survival in incident dialysis patients.

N. Powe, J. Coresh, A. Levey, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.

E. Bedrick, Ajay K. Singh, K. Servilla, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease

Kaleab Z. Abebe, S. Seliger, K. Hallows, 2018, American Journal of Nephrology.

Peripherally Inserted Central Catheters and Hemodialysis Outcomes.

D. Weiner, D. Miskulin, R. Ruthazer, 2016, Clinical journal of the American Society of Nephrology : CJASN.

A validation study of the Canadian Organ Replacement Register.

A. Garg, B. Hemmelgarn, D. Miskulin, 2011, Clinical journal of the American Society of Nephrology : CJASN.

High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis.

H. Tighiouart, D. Weiner, D. Miskulin, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Trends in anemia management in US hemodialysis patients 2004–2010

P. Ephraim, N. Tangri, K. Bandeen-Roche, 2013, BMC Nephrology.

Anemia Management in Chronic Kidney Disease: Bursting the Hemoglobin Bubble

D. Weiner, D. Miskulin, 2010, Annals of Internal Medicine.

Reducing versus discontinuing erythropoietin at high hemoglobin levels.

Ajay K. Singh, D. Weiner, D. Miskulin, 2007, Journal of the American Society of Nephrology : JASN.

Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.

M. Rudnick, D. Miskulin, H. Litt, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

PERITUBULAR CAPILLARY BASEMENT MEMBRANE REDUPLICATION IN ALLOGRAFTS AND NATIVE KIDNEY DISEASE: A Clinicopathologic Study of 278 Consecutive Renal Specimens

D. Miskulin, D. Muruve, I. Gedeon, 2001, Transplantation.

Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Christopher T. Chan, A. Davenport, V. Jha, 2020, Kidney international.

Closeout of the HALT-PKD trials.

Kaleab Z. Abebe, K. Bae, C. Moore, 2015, Contemporary clinical trials.

A β-Blocker Trial in Dialysis Patients: Is It Feasible and Worthwhile?

M. Sarnak, D. Miskulin, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease

Kaleab Z. Abebe, K. Bae, C. Moore, 2018, Kidney international reports.

Design of the Blood Pressure Goals in Dialysis Pilot Study

E. Bedrick, M. Unruh, J. Kusek, 2014, The American journal of the medical sciences.

Satisfaction with Care of Patients on Hemodialysis.

M. Richardson, C. Stidley, D. Miskulin, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Association of nutritional markers with physical and mental health status in prevalent hemodialysis patients from the HEMO study.

J. Dwyer, D. Miskulin, G. Yan, 2002, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Vascular imaging for hemodialysis vascular access planning

D. Weiner, D. Miskulin, R. Ruthazer, 2017, Hemodialysis international. International Symposium on Home Hemodialysis.

We use our judgment and do the best we can

D. Miskulin, K. Meyer, 2020, Seminars in dialysis.

Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial Participants

Kaleab Z. Abebe, S. Seliger, Hui Li, 2021, Kidney360.

Key comorbid conditions that are predictive of survival among hemodialysis patients.

H. Tighiouart, A. Levey, J. Bragg-Gresham, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies

Kaleab Z. Abebe, A. Chapman, M. Chonchol, 2021, Kidney medicine.

ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.

Kaleab Z. Abebe, K. Bae, A. Chapman, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments.

N. Powe, J. Coresh, A. Levey, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Comparison of Prescribed and Measured Dialysate Sodium: A Quality Improvement Project.

D. Weiner, D. Miskulin, P. Zager, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial.

J. Kusek, D. Miskulin, Alice A. Martin, 2001, Kidney international.

Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.

N. Tangri, J. Griffith, D. Miskulin, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.

H. Tighiouart, D. Miskulin, R. Wald, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Demographics and trends in overweight and obesity in patients at time of kidney transplantation.

A. Levey, I. Rosenberg, D. Miskulin, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients.

D. Weiner, D. Miskulin, K. Meyer, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Chronic disease burdens of incident U.S. dialysis patients, 1996 - 2015 .

J. Bragg-Gresham, D. Miskulin, Kevin He, 2019, Clinical nephrology.

Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months

A. Wu, P. Ephraim, A. McDermott, 2013, BMC Nephrology.

Intravenous iron administration strategies and anemia management in hemodialysis patients

P. Ephraim, N. Tangri, K. Bandeen-Roche, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Seroresponse to Inactivated and Recombinant Influenza Vaccines among Maintenance Hemodialysis Patients

D. Weiner, D. Miskulin, H. Manley, 2021, medRxiv.

Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial.

H. Tighiouart, D. Weiner, D. Miskulin, 2016, Journal of the American Society of Nephrology : JASN.

Imperial or empirical measures of dialysis quality?

D. Miskulin, K. Meyer, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

EDITORIALS Imperial or Empirical Measures of Dialysis Quality

D. Miskulin, 2007 .

Updated comorbidity assessments and outcomes in prevalent hemodialysis patients

T. Greene, T. Chang, G. Chertow, 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

Characterizing Comorbidity in Dialysis Patients: Principles of Measurement and Applications in Risk Adjustment and Patient Care

D. Miskulin, 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease.

N. Powe, N. Terrin, J. Coresh, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comorbidity Assessment in Hemodialysis and Peritoneal Dialysis Using the Index of Coexistent Disease

C. Schmid, S. Greenfield, A. Levey, 2000, Seminars in dialysis.

Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial.

Kaleab Z. Abebe, S. Seliger, K. Hallows, 2020, Kidney360.

Intravenous iron exposure and mortality in patients on hemodialysis.

A. Wu, P. Ephraim, A. McDermott, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.

Kaleab Z. Abebe, K. Bae, A. Chapman, 2017, Journal of the American Society of Nephrology : JASN.

COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider

D. Weiner, D. Miskulin, H. Manley, 2021, American Journal of Kidney Diseases.

Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization

A. Levey, K. Uhlig, A. Earley, 2012, Annals of Internal Medicine.

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

A. Cheung, D. Cifelli, R. Madigan, 2019, Journal of the American Society of Nephrology : JASN.

Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD).

Kaleab Z. Abebe, K. Bae, C. Tao, 2021, Kidney international.

Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study.

G. Eknoyan, A. Cheung, H. Tighiouart, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

E. Bedrick, K. Servilla, D. Miskulin, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Intradialytic hypotension

Ambreen Gul, D. Miskulin, P. Zager, 2016, Current opinion in nephrology and hypertension.

Kaleab Z. Abebe, K. Bae, C. Moore, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

R. Karas, M. Sarnak, K. Heffernan, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

SARS-CoV-2 vaccine effectiveness and breakthrough infections in maintenance dialysis patients

D. Miskulin, H. Manley, E. Lacson, 2021, medRxiv.

Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months

D. Weiner, D. Miskulin, H. Manley, 2021, medRxiv.

Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.

M. Sarnak, R. Perrone, D. Miskulin, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Blood Pressure Management in Hemodialysis Patients: What We Know And What Questions Remain

Daniel E Weiner, D. Weiner, D. Miskulin, 2017, Seminars in dialysis.

Epidemiology of hypertension in CKD.

D. Miskulin, P. Zager, B. Horowitz, 2015, Advances in chronic kidney disease.

BP in Dialysis: Results of a Pilot Study.

Mahboob Rahman, A. Levey, R. Kwong, 2017, Journal of the American Society of Nephrology : JASN.

Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients

A. Wu, P. Ephraim, A. McDermott, 2017, Medicine.

Predialysis health, dialysis timing, and outcomes among older United States adults.

N. Powe, A. Wu, P. Ephraim, 2014, Journal of the American Society of Nephrology : JASN.

Variation in fistula use across dialysis facilities: is it explained by case-mix?

N. Tangri, D. Miskulin, K. Meyer, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Angiotensin blockade in late autosomal dominant polycystic kidney disease.

Kaleab Z. Abebe, C. Moore, A. Chapman, 2014, The New England journal of medicine.

Racial differences in health-related quality of life among hemodialysis patients.

R. Hays, M. Unruh, J. Kusek, 2004, Kidney international.

Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?

E. Bedrick, C. Stidley, K. Servilla, 2007, Journal of the American Society of Nephrology : JASN.

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.

L. Stevens, M. Tonelli, B. Manns, 2004, Kidney international.

Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

P. Ephraim, A. McDermott, N. Tangri, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Transfers to Hemodialysis Among US Patients Initiating Renal Replacement Therapy With Peritoneal Dialysis.

D. Weiner, D. Miskulin, R. Ruthazer, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study

N. Powe, A. Wu, P. Ephraim, 2012, BMC Nephrology.

Age, race, diabetes, blood pressure, and mortality among hemodialysis patients.

E. Bedrick, K. Servilla, D. Miskulin, 2010, Journal of the American Society of Nephrology : JASN.

Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Diego R. Martín, Kaleab Z. Abebe, J. Miller, 2012, Kidney international.

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients

D. Weiner, D. Miskulin, H. Manley, 2021, American Journal of Kidney Diseases.

Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants

Kaleab Z. Abebe, S. Seliger, Hui Li, 2022, Kidney international reports.

Predialysis systolic BP variability and outcomes in hemodialysis patients.

Aidan McDermott, Albert W Wu, Tariq Shafi, 2014, Journal of the American Society of Nephrology : JASN.

Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease

A. Chapman, V. Torres, J. Bost, 2011, Blood pressure monitoring.

The Influence of Age on Changes in Health‐Related Quality of Life over Three Years in a Cohort Undergoing Hemodialysis

M. Rocco, A. Newman, T. Greene, 2008, Journal of the American Geriatrics Society.

Serial SARS-CoV-2 antibody titers in vaccinated dialysis patients: prevalence of unrecognized infection and duration of seroresponse

D. Weiner, D. Miskulin, H. Manley, 2023, medRxiv.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

A. Wu, P. Ephraim, N. Tangri, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

An instrumental variable approach finds no associated harm or benefit from early dialysis initiation in the United States

N. Powe, A. Wu, P. Ephraim, 2014, Kidney international.

Multidisciplinary Medication Therapy Management and Hospital Readmission in Patients Undergoing Maintenance Dialysis: A Retrospective Cohort Study.

D. Weiner, D. Miskulin, H. Manley, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Influenza in dialysis patients: an opportunity to decrease mortality?

D. Miskulin, 2019, Current opinion in nephrology and hypertension.

Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.

Diego R. Martín, Kaleab Z. Abebe, J. Miller, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Temporal trends in health-related quality of life among hemodialysis patients in the United States.

J. Griffith, M. Richardson, D. Miskulin, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).

Jon Neville, Eslie Dennis, Bron Kisler, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluation of non-response to the In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) survey

H. Tighiouart, M. Richardson, J. Fenton, 2018, BMC Health Services Research.

Drug Selection for Treating Hypertension in Dialysis Patients: More to Consider than BP-Lowering Potency.

T. Shafi, D. Miskulin, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.

Kaleab Z. Abebe, K. Bae, C. Moore, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Case-mix factors explain the survival advantage of Hispanic and racial minority patients on hemodialysis

D. Miskulin, 2007, Nature Clinical Practice Nephrology.

High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients.

D. Weiner, D. Miskulin, H. Manley, 2020, American Journal of Kidney Diseases.

Acknowledgments

S. Oparil, A. Kribben, M. Nangaku, 1998, Psychometrika.

mRNA COVID-19 Vaccine for People with Kidney Failure.

D. Miskulin, C. Combe, 2021, American Society of Nephrology. Clinical Journal.

Both patient and facility contribute to achieving the Centers for Medicare and Medicaid Services' pay-for-performance target for dialysis adequacy.

N. Tangri, H. Tighiouart, D. Miskulin, 2011, Journal of the American Society of Nephrology : JASN.

High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis.

H. Tighiouart, D. Weiner, D. Miskulin, 2018, Clinical journal of the American Society of Nephrology : CJASN.

The HALT polycystic kidney disease trials: design and implementation.

J. Miller, M. Hogan, R. Perrone, 2010, Clinical journal of the American Society of Nephrology : CJASN.

A validation study of the Canadian Organ Replacement Register.

A. Garg, B. Hemmelgarn, D. Miskulin, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Infection Monitoring in Dialysis Units: A Plea for "Cleaner" Data.

D. Miskulin, Ambreen Gul, 2017, American Society of Nephrology. Clinical Journal.

Key comorbid conditions that are predictive of survival among hemodialysis patients.

H. Tighiouart, A. Levey, J. Bragg-Gresham, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Comparison of Dialysis Unit and Home Blood Pressures: An Observational Cohort Study.

V. Pankratz, R. Kwong, D. Miskulin, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis

D. Weiner, D. Miskulin, H. Manley, 2022, American Journal of Kidney Diseases.

Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?

R. Perrone, D. Miskulin, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.